Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick G Hamel

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Translational Research : the Journal of Laboratory and Clinical Medicine|March 23, 2010
Telomeres and type 2 diabetesFrederick G Hamel
Metabolism: Clinical and Experimental|May 9, 2009
Preliminary report: inhibition of cellular proteasome activity by free fatty acidsFrederick G Hamel
Atherosclerosis|June 9, 2005
Neointimal hyperplasia and vascular endothelial growth factor expression are increased in normoglycemic, insulin resistant, obese fatty ratsCyrus V Desouza, Moira Gerety, Frederick G Hamel
Vascular Pharmacology|June 13, 2009
Effects of a PPAR-gamma agonist, on growth factor and insulin stimulated endothelial cellsCyrus V Desouza, Moira Gerety, Frederick G Hamel
Vascular Pharmacology|December 5, 2006
Long-term effects of a PPAR-gamma agonist, pioglitazone, on neointimal hyperplasia and endothelial regrowth in insulin resistant ratsCyrus V Desouza, Moira Gerety, Frederick G Hamel
World Journal of Gastroenterology|June 28, 2017
Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosisRobert G Bennett, Ronda L Simpson, Frederick G Hamel
Bioactive Materials|February 25, 2026
Innovative strategies for diabetic peripheral neuropathy: From clinical management to emerging bioengineering solutionsZhi He, Jie Diao, Frederick G Hamel, et al.
Diabetes|August 28, 2003
An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell culturesRobert G Bennett, Frederick G Hamel, William C Duckworth
Annals of the New York Academy of Sciences|May 7, 2009
Degradation of relaxin family peptides by insulin-degrading enzymeRobert G Bennett, Dean G Heimann, Frederick G Hamel
Endocrinology|May 15, 2003
In vitro inhibition of insulin-degrading enzyme by long-chain fatty acids and their coenzyme A thioestersFrederick G Hamel, Jennifer L Upward, Robert G Bennett
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Translational Research : the Journal of Laboratory and Clinical Medicine|March 23, 2010
Telomeres and type 2 diabetesFrederick G Hamel
Metabolism: Clinical and Experimental|May 9, 2009
Preliminary report: inhibition of cellular proteasome activity by free fatty acidsFrederick G Hamel
Atherosclerosis|June 9, 2005
Neointimal hyperplasia and vascular endothelial growth factor expression are increased in normoglycemic, insulin resistant, obese fatty ratsCyrus V Desouza, Moira Gerety, Frederick G Hamel
Vascular Pharmacology|June 13, 2009
Effects of a PPAR-gamma agonist, on growth factor and insulin stimulated endothelial cellsCyrus V Desouza, Moira Gerety, Frederick G Hamel
Vascular Pharmacology|December 5, 2006
Long-term effects of a PPAR-gamma agonist, pioglitazone, on neointimal hyperplasia and endothelial regrowth in insulin resistant ratsCyrus V Desouza, Moira Gerety, Frederick G Hamel
World Journal of Gastroenterology|June 28, 2017
Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosisRobert G Bennett, Ronda L Simpson, Frederick G Hamel
Bioactive Materials|February 25, 2026
Innovative strategies for diabetic peripheral neuropathy: From clinical management to emerging bioengineering solutionsZhi He, Jie Diao, Frederick G Hamel, et al.
Diabetes|August 28, 2003
An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell culturesRobert G Bennett, Frederick G Hamel, William C Duckworth
Annals of the New York Academy of Sciences|May 7, 2009
Degradation of relaxin family peptides by insulin-degrading enzymeRobert G Bennett, Dean G Heimann, Frederick G Hamel
Endocrinology|May 15, 2003
In vitro inhibition of insulin-degrading enzyme by long-chain fatty acids and their coenzyme A thioestersFrederick G Hamel, Jennifer L Upward, Robert G Bennett
Pageof 3